Rockefeller Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,000
| Closed | -$215K | – | 4198 |
|
|
2022
Q4 | $215K | Sell |
8,000
-42,000
| -84% | -$1.13M | ﹤0.01% | 1634 |
|
|
2022
Q3 | $898K | Sell |
50,000
-12,500
| -20% | -$225K | ﹤0.01% | 1052 |
|
|
2022
Q2 | $776K | Sell |
62,500
-4,500
| -7% | -$55.9K | ﹤0.01% | 1082 |
|
|
2022
Q1 | $892K | Buy |
67,000
+17,000
| +34% | +$226K | ﹤0.01% | 1091 |
|
|
2021
Q4 | $778K | Buy |
50,000
+18,000
| +56% | +$280K | ﹤0.01% | 1143 |
|
|
2021
Q3 | $718K | Sell |
32,000
-2,500
| -7% | -$56.1K | ﹤0.01% | 1126 |
|
|
2021
Q2 | $785K | Buy |
34,500
+9,600
| +39% | +$218K | ﹤0.01% | 1020 |
|
|
2021
Q1 | $512K | Buy |
+24,900
| New | +$512K | ﹤0.01% | 1013 |
|